Filing Details

Accession Number:
0000820081-16-000055
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-10 16:27:29
Reporting Period:
2016-05-09
Filing Date:
2016-05-10
Accepted Time:
2016-05-10 16:27:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820081 Cambrex Corp CBM Pharmaceutical Preparations (2834) 222476135
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192621 M Steven Klosk One Meadowlands Plaza
East Rutherford NJ 07073
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-09 14,005 $4.38 147,333 No 4 M Direct
Common Stock Disposition 2016-05-09 14,005 $49.00 133,328 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2016-05-09 14,005 $0.00 14,005 $4.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-04-21 No 4 M Direct
Footnotes
  1. The option representing a right to purchase 150,000 shares became exercisable in four equal installments beginning April 21, 2011 which was the first anniversary of the date on which the option was granted.